Supercharge Your Innovation With Domain-Expert AI Agents!

A kind of anti-tuberculosis mycobacterium cfp-10 protein monoclonal antibody and application thereof

A CFP-10, monoclonal antibody technology, applied in the field of biomedicine

Active Publication Date: 2020-11-13
东方海洋(北京)医学研究院有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is still a lack of effective monoclonal antibodies for the immunodetection of CFP-10 antigen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of anti-tuberculosis mycobacterium cfp-10 protein monoclonal antibody and application thereof
  • A kind of anti-tuberculosis mycobacterium cfp-10 protein monoclonal antibody and application thereof
  • A kind of anti-tuberculosis mycobacterium cfp-10 protein monoclonal antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1 immunogen preparation

[0026] Using the DNA of Mycobacterium tuberculosis H37Rv strain as a template, the amplification primers were designed for the open reading frame region of CFP-10 as shown in Table 1. PCR amplification was performed, and the fragment was digested and connected into the prokaryotic expression vector pBVIL1 to construct the pBVIL1-CFP-10 recombinant plasmid.

[0027] Table 1 Amplification primers of CFP-10 fragment

[0028]

[0029] Transform the recombinant expression plasmid with correct sequencing into HB101 competent cells, pick a single colony in 3ml LB liquid medium containing ampicillin sodium, shake and culture overnight at 37°C, inoculate in fresh LB liquid medium the next day and cultivate until After the logarithmic phase, induce overnight at a temperature of 42°C. Perform SDS-PAGE gel electrophoresis to analyze the expression of the inclusion body of the target protein in the precipitate, and the results are as follows...

Embodiment 2

[0031] Embodiment 2 hybridoma cell lines are established

[0032] Eight-week-old BALB / C male mice were used to inject CFP-10 antigen plus an equal amount of Freund's complete adjuvant into the back and intraperitoneal injection of mice (50 μg / mouse); the second and third immunizations with the same dose were carried out at the fourth and eighth weeks. With Freund's incomplete adjuvant, spleen cells were taken for fusion after 3 days.

[0033] Resuscitate SP20 myeloma cells so that they are in logarithmic growth phase. The immunized BALB / c mice were taken, and the eyeballs were removed to collect blood for the positive control serum. At the same time, the mice were killed by cervical dislocation, and the body surface was disinfected with 75% alcohol for 3-5 minutes. The spleen was collected to prepare a spleen cell suspension.

[0034] Take the above splenocytes and myeloma cells according to the ratio of 5:1, mix them in serum-free DMEM medium, centrifuge at 1500rpm for 5 min...

Embodiment 3

[0036] Example 3 Preparation of monoclonal antibody and its subtype analysis

[0037] The C-10 hybridoma cells were revived and cultured in 1640 medium containing 10% fetal bovine serum. Each BALB / c mouse was intraperitoneally injected with 0.5ml of liquid paraffin. Collect the cells after 10 days, resuspend the cells with 10ml normal saline, and inject 0.5ml intraperitoneally into each mouse (the cell density is about 1×10 7 pieces / ml). After 2 weeks, ascitic fluid was collected.

[0038] 1) Purification of monoclonal antibodies

[0039] Antibody purification was carried out with Melon Gel Monoclonal IgG Purification Kit from Thermo Company, and the results were as follows figure 2 shown. The purified antibody was stored at -20°C after aliquoting.

[0040] 2) Subclass identification

[0041] Using the Pierce Papid Isotyping Kit-Mouse kit antibody subtype identification, the monoclonal antibody was identified as the mouse IgG1 subtype, such as image 3 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a monocloning antibody resisting m.tuberculosis CFP-10 protein and application thereof. For the monocloning antibody, the amino acid sequence of a light chain CDR1 is as shownin SEQ ID NO. 1; the amino acid sequence of a light chain CDR2 is as shown in SEQ ID NO. 2; the amino acid sequence of a light chain CDR3 is as shown in SEQ ID NO. 3; the amino acid sequence of a heavy chain CDR1 is as shown in SEQ ID NO. 4; the amino acid sequence of a heavy chain CDR2 is as shown in SEQ ID NO. 5; the amino acid sequence of a heavy chain CDR3 is as shown in SEQ ID NO. 6. The monocloning antibody resisting m.tuberculosis CFP-10 protein has very good specificity and titer, and can be used to detect m.tuberculosis CFP-10 protein.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a monoclonal antibody against Mycobacterium tuberculosis CFP-10 protein and application thereof. Background technique [0002] Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis infection. It is mainly transmitted through the respiratory tract. As the disease continues to deteriorate, it will lead to systemic multi-system diseases. It is a chronic infectious disease that seriously damages human health. According to the statistics of the World Health Organization (WHO), in 2016, there were about 10.4 million newly discovered tuberculosis cases in the world, and China's new cases accounted for 8.6% of the world's total, ranking third in the world with a high burden of tuberculosis. Therefore, the prevention and control of tuberculosis epidemic is urgent, and early diagnosis and timely standardized treatment are particularly important. [0003] The cultu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/12G01N33/68G01N33/577
CPCC07K16/1289C07K2317/56G01N33/577G01N33/68G01N2333/35
Inventor 张贺秋冯晓燕张佳危利张玲王超男车志远张磊
Owner 东方海洋(北京)医学研究院有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More